{"ticker": {"uuid": "cefe213c-bea8-4921-9171-37dbf35a0275", "symbol": "4527", "name": "Rohto Pharmaceutical Co.,Ltd.", "exchange": "JPX", "country": "JP", "sector": "Consumer Defensive", "industry": "Household & Personal Products"}, "articles": [{"title": "Price to earnings forward of Rohto Pharmaceutical Co., Ltd. \u2013 TSE:4527", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQOU9oUFVEZHlQYXRkcHhtUGVUTHFaWVd3TlFTWDZ3eFJDVE9CYXlzUVZ2cEs2NWRvMmVlem1hc0lxM3ZYbzUxQVZXdDVKeWdFcmdnN1pMdzRCbEp4dnotdWRoRTBub1h6ZmUyM3MyQVh2WUZVVHcyRjFueGhweVFKcFpwb3J6SmVETGtWaTRuTG9VcTdfYzlCTHRhUU1lUQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:57:30+00:00", "published_display": "11 Jul 2026 02:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Did Rohto (TSE:4527) Shareholders\u2019 Support For Management Quietly Recalibrate Its Governance Risk Profile?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T18:34:46+00:00", "published_display": "07 Jul 2026 18:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Luminopia Announces First International Licensing Agreement with ROHTO Pharmaceutical to Launch Pediatric Amblyopia Treatment in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxOMXdJbmpwOEcwLWhYSzFkTXVQUDh2MDhXU1p1dWg5OTlQX0FYVkJzYUFhcnpPSzVkQ2RsWm82dmdIR0wxdllfeXA5bGE0azhhVlVCQlZ4TTRNeUZ1N0o5TzQ4LTZ5MV9WaDdkX0RqbWF4ZTRhVjBWS3ozMHluOGVWSEw2aWJGb3Q3WDlhY0hMZ0RHWUlLb24td3d6OElSMUp1LTVHYlNIdS1Id3JKelpZYkRqNlZ5dWdpbTNTM2VPc2M1SEpKOTdKX29lbU0wX3lRLTJlV2Z1ZWhuY2RpQkFjajVCNmpvdzhhek1STnh6bUV5Z3lXNy0yRzkzRHVyQ09ELURMS25hU0JmSGJMdWN0em1XZ2VKVGpndFE?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rohto Pharmaceutical (TSE:4527) Valuation After Higher Year End Dividend And New Earnings Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOdjdyWG01Y1VDNW1vVmkzTzBxVVVyNUU0TXZ4UktULWsySGM1NE94djV0LWJnZmhhaXZQTjh2WlVybVlEN0xXRDlsQXNWcWhHamVSaVJKSHlZOFR0NzU3OVhudlo1b3l0OEo2aWdTM2tKSWptbzhLcWI1NkNFTGFIZDZDTC04NTB2ZkNJaGcyNXEycXZEWTJSMlBabmtkSG9qdDhKMk5TNA?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxQSkRtM0ZWdDVUVnR0VlJ1SHA5cHEtYjJza0RJaHJUSGRySVZCS0gyNHVDNjFTZnJmbmF2WXFsYVRZTzltN0pZeUZlTGVxUXR2WFozRjVsZUZYcTdLczl4R3JNTmtyaWQ5TjNfb00zRkJ6TGdMUzVMVlpTZFhuMFQyMmRCZUNrNnZtdGxaUWUxSzFkVktNb015bmNON29vdko4b2R5d0xmWHR4Y3U2d2dXYlRxekdGd1BEemNSRjhWWHlRSjZpdHpOcWY5cVh1VWpJZFBMVHpfX3pwNUhnSUdDQ0ZGMHA0NDVzYlJZOEQ3SGMycEpObTQ4ajNnczVNWk8tZXljeWpFQ0E0eFVNWFhjZ1pwYlU?oc=5", "source_name": "Business Wire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CFO Message | Investor Relations | ROHTO Pharmaceutical Co., Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE0yZm5JNnRERElidl9nd1dnb2tSVzZYS2pYVGxVUkx3Z3FFQ3pNdGNmVm1mQ09XdUhRS0JBdzlWTDhZakFycFZTdFBqeGhyNms?oc=5", "source_name": "rohto.co.jp", "published_at": "2026-03-31T09:07:06+00:00", "published_display": "31 Mar 2026 09:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rohto Eye Vision, now available, featuring Japan's only", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTFBDMkE2Qi15bnVyWHVhb1U5R2FKejYxa1BoWDMtWURCbk5xWXdxZW9odzdrQXNqaFYwM3NTd25zWmpDU3BlRkNjN1poZXUxajNLMllmZmlQaWMxeURIS2lCVWJ3?oc=5", "source_name": "rohto.co.jp", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rohto Pharmaceutical Co., Ltd.'s eye supplement \"ROHTO V5 a\" receives the 12th Health and Medical Award from the Japan Society for Health and Medical Care | News | ROHTO Pharmaceutical Co., Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE92OVR0cDdfcTQ0eE5PemxQT2RaWk1jUUlRVHY2VVQ5NXNiZXYwVHpvbU8yWno5R05JX0hZQnVLenkyM1NCOGk3Qi1tWkRJRnBiOVdBX092NXZMemJoYVdZc1p3?oc=5", "source_name": "rohto.co.jp", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to earnings forward of Rohto Pharmaceutical Co., Ltd. \u2013 TSE:4527", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQOU9oUFVEZHlQYXRkcHhtUGVUTHFaWVd3TlFTWDZ3eFJDVE9CYXlzUVZ2cEs2NWRvMmVlem1hc0lxM3ZYbzUxQVZXdDVKeWdFcmdnN1pMdzRCbEp4dnotdWRoRTBub1h6ZmUyM3MyQVh2WUZVVHcyRjFueGhweVFKcFpwb3J6SmVETGtWaTRuTG9VcTdfYzlCTHRhUU1lUQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:57:30+00:00", "published_display": "11 Jul 2026 02:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Did Rohto (TSE:4527) Shareholders\u2019 Support For Management Quietly Recalibrate Its Governance Risk Profile?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T18:34:46+00:00", "published_display": "07 Jul 2026 18:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Luminopia Announces First International Licensing Agreement with ROHTO Pharmaceutical to Launch Pediatric Amblyopia Treatment in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxOMXdJbmpwOEcwLWhYSzFkTXVQUDh2MDhXU1p1dWg5OTlQX0FYVkJzYUFhcnpPSzVkQ2RsWm82dmdIR0wxdllfeXA5bGE0azhhVlVCQlZ4TTRNeUZ1N0o5TzQ4LTZ5MV9WaDdkX0RqbWF4ZTRhVjBWS3ozMHluOGVWSEw2aWJGb3Q3WDlhY0hMZ0RHWUlLb24td3d6OElSMUp1LTVHYlNIdS1Id3JKelpZYkRqNlZ5dWdpbTNTM2VPc2M1SEpKOTdKX29lbU0wX3lRLTJlV2Z1ZWhuY2RpQkFjajVCNmpvdzhhek1STnh6bUV5Z3lXNy0yRzkzRHVyQ09ELURMS25hU0JmSGJMdWN0em1XZ2VKVGpndFE?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rohto Pharmaceutical (TSE:4527) Valuation After Higher Year End Dividend And New Earnings Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOdjdyWG01Y1VDNW1vVmkzTzBxVVVyNUU0TXZ4UktULWsySGM1NE94djV0LWJnZmhhaXZQTjh2WlVybVlEN0xXRDlsQXNWcWhHamVSaVJKSHlZOFR0NzU3OVhudlo1b3l0OEo2aWdTM2tKSWptbzhLcWI1NkNFTGFIZDZDTC04NTB2ZkNJaGcyNXEycXZEWTJSMlBabmtkSG9qdDhKMk5TNA?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxQSkRtM0ZWdDVUVnR0VlJ1SHA5cHEtYjJza0RJaHJUSGRySVZCS0gyNHVDNjFTZnJmbmF2WXFsYVRZTzltN0pZeUZlTGVxUXR2WFozRjVsZUZYcTdLczl4R3JNTmtyaWQ5TjNfb00zRkJ6TGdMUzVMVlpTZFhuMFQyMmRCZUNrNnZtdGxaUWUxSzFkVktNb015bmNON29vdko4b2R5d0xmWHR4Y3U2d2dXYlRxekdGd1BEemNSRjhWWHlRSjZpdHpOcWY5cVh1VWpJZFBMVHpfX3pwNUhnSUdDQ0ZGMHA0NDVzYlJZOEQ3SGMycEpObTQ4ajNnczVNWk8tZXljeWpFQ0E0eFVNWFhjZ1pwYlU?oc=5", "source_name": "Business Wire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CFO Message | Investor Relations | ROHTO Pharmaceutical Co., Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE0yZm5JNnRERElidl9nd1dnb2tSVzZYS2pYVGxVUkx3Z3FFQ3pNdGNmVm1mQ09XdUhRS0JBdzlWTDhZakFycFZTdFBqeGhyNms?oc=5", "source_name": "rohto.co.jp", "published_at": "2026-03-31T09:07:06+00:00", "published_display": "31 Mar 2026 09:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rohto Eye Vision, now available, featuring Japan's only", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTFBDMkE2Qi15bnVyWHVhb1U5R2FKejYxa1BoWDMtWURCbk5xWXdxZW9odzdrQXNqaFYwM3NTd25zWmpDU3BlRkNjN1poZXUxajNLMllmZmlQaWMxeURIS2lCVWJ3?oc=5", "source_name": "rohto.co.jp", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rohto Pharmaceutical Co., Ltd.'s eye supplement \"ROHTO V5 a\" receives the 12th Health and Medical Award from the Japan Society for Health and Medical Care | News | ROHTO Pharmaceutical Co., Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE92OVR0cDdfcTQ0eE5PemxQT2RaWk1jUUlRVHY2VVQ5NXNiZXYwVHpvbU8yWno5R05JX0hZQnVLenkyM1NCOGk3Qi1tWkRJRnBiOVdBX092NXZMemJoYVdZc1p3?oc=5", "source_name": "rohto.co.jp", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 8, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 6, "score": 50, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 3.3, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 2430.0, "latest_week": "2026-07-10", "one_week_move": 1.0, "four_week_move": 4.6, "twelve_week_move": 1.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.359286, "market_dynamics_buy_signal": false, "relative_strength": -23.842598, "fair_value_gap": -11.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.0918, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.0% over one week, +4.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "rohto.co.jp", "count": 3}, {"label": "TradingView", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "Market source", "count": 1}, {"label": "Business Wire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.0% over one week, +4.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to earnings forward of Rohto Pharmaceutical Co., Ltd. \u2013 TSE:4527"}], "updated_at": "2026-07-17T08:18:40.729250+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}